Amrinder Singh

Amrinder Singh is a Partner at Vensana Capital, where he invests in venture and growth-stage healthcare companies across medical technology, medical devices, diagnostics, digital health, and healthcare services. He invests from early stage through Series C in North America (primarily the United States), with activity in regions including Minnesota, California, Massachusetts, Colorado, the Midwestern US, and the Greater Minneapolis–Saint Paul and Greater Philadelphia areas. He has invested in companies like Luna Diabetes, Alleviant Medical, Nyra Medical, Cleerly, and Inari Medical. Before becoming Partner, he was a Principal at Vensana Capital; he also served as an Artificial Intelligence Working Group Advisor to the Medical Device Manufacturers Association (MDMA). Earlier, he held senior venture capital and strategy roles at Medtronic and product and engineering roles at Thoratec (now part of St. Jude Medical), following an R&D engineering internship at Acumen Medical. Amrinder studied at Northwestern University – Kellogg School of Management and the University of California, Davis, and lives in Minneapolis.